Quick Answer
OCD relapse after stopping an SSRI is common. The International OCD Foundation notes that SSRIs help while you take them but don't appear to keep working years after stopping, and that relapse rates after discontinuation are high, so long-term treatment is commonly recommended. ERP may reduce relapse risk. Any decision to stop should involve a slow taper.
Understanding OCD Relapse After Stopping an SSRI
After months of feeling better, many people wonder whether they still need OCD medication. It’s a reasonable question. The International OCD Foundation explains that OCD is often a chronic condition and that SSRIs help while you take them but don’t appear to have lasting effects years after stopping. It notes the relapse rate among people who stop SSRI treatment is high, which is why long-term treatment is commonly recommended. That doesn’t mean you can never stop. It means stopping should be planned carefully and monitored. This guide is part of our full set of New York OCD guides.
ERP can help. The foundation notes that for some people, engaging in exposure and response prevention may reduce the risk of relapse that can follow stopping an SSRI. Skills learned in ERP, like resisting compulsions and tolerating uncertainty, remain useful after medication ends. Many clinicians suggest having solid ERP skills in place before a taper. Our guide on coordinating ERP and psychiatry explains how therapy and medication can support each other.
For New Yorkers feeling well on OCD medication and wondering about stopping, a plan beats a sudden decision. The International OCD Foundation notes that it takes an average of more than seven years for someone to receive an accurate OCD diagnosis. Secure video visits from anywhere in New York can make it easier to start OCD care without adding travel to an already crowded day.
Why relapse happens, tapering safely, and ERP as protection are the three topics this guide covers.
Early warning signs
Early signs of relapse include rituals taking a little more time, new avoidance, more reassurance-seeking, intrusive thoughts feeling stickier or loved ones noticing changes. Catching these early makes it easier to respond. Returning to ERP practice, contacting your clinician and possibly adjusting the taper can help. You don’t need to wait until symptoms are severe.
If OCD returns
If OCD returns after stopping, restarting the same medication often helps, though response may take time again. Many people also return to ERP. Relapse isn’t a failure. It’s useful information about what your OCD needs. Some people decide long-term medication is right for them, and that’s a valid choice.
Key Takeaways
- Relapse is common after stopping SSRIs for OCD.
- Long-term treatment is commonly recommended, per the IOCDF.
- ERP may help protect against relapse after discontinuation.
- A slow, planned taper is safer than stopping suddenly.
OCD Relapse After Stopping an SSRI at a glance
| Feature | Discontinuation symptoms | OCD relapse |
|---|---|---|
| Timing | Within days of stopping | Weeks to months later |
| Symptoms | Dizziness, irritability, flu-like feelings | Obsessions and rituals return |
| Course | Usually ease over weeks | Tend to persist |
| Response | Slower taper helps | Restart treatment, ERP |
Tapering safely
If you and your prescriber decide to try stopping, a slow taper is safer than stopping suddenly. Doses are reduced gradually over weeks to months, with pauses if symptoms or discontinuation effects appear. Timing matters too. Choosing a stable period, rather than during a move, job change or other stress, gives the strongest chance. Tracking the Y-BOCS during and after the taper helps catch early signs of return.
Discontinuation vs. relapse
Discontinuation symptoms, like dizziness, irritability, flu-like feelings, sleep changes and electric-shock sensations, can appear within days of reducing or stopping an SSRI. They usually ease over weeks and are helped by a slower taper. OCD relapse, the return of obsessions and rituals, tends to appear weeks to months later and persists. Knowing the difference helps you respond appropriately. Our guides on coordinating ERP and psychiatry and the annual OCD review cover related topics.
Relapse prevention for New York patients
Taper plans and check-ins can happen by secure video. Visits run by secure video anywhere in New York, while you’re physically in the state. The practice is in-network with Aetna and Cigna; confirm your New York plan with the office, and see self-pay fees on the Good Faith Estimate page.
Deciding together
The decision to continue or stop is personal and shared. Factors include how severe OCD was, how many episodes you’ve had, side effects, life plans such as pregnancy, and your preferences. Your prescriber can discuss risks and benefits. There’s no one right answer for everyone.
When to call
Contact your clinician if obsessions and rituals return, discontinuation symptoms are hard to manage, or mood changes. New thoughts of self-harm need immediate help through 988 or 911. Don’t stop medication suddenly without a plan. Relapse is common and treatable.
Planning a taper together often starts with a simple written plan. It lists the dose steps and how long each will last, which signs would prompt a pause, and how often you’ll check in. It also notes which ERP exercises you’ll keep practicing along the way. Sharing the plan with a trusted person can help, since loved ones often notice early changes first. Writing it down turns a vague intention into a clear process. If the taper doesn’t work out, the plan also makes it easy to return to what helped.
The Bottom Line
OCD Relapse After Stopping an SSRI is common and treatable, and careful care can make daily life feel more manageable.
Frequently Asked Questions
Will my OCD come back if I stop my SSRI?
Relapse is common after stopping SSRIs for OCD. The International OCD Foundation notes SSRIs help while you take them but don't appear to keep working years after stopping. That's why long-term treatment is commonly recommended. ERP may reduce relapse risk. Any decision to stop should be planned with your prescriber.
How should I stop my OCD medication?
A slow, planned taper is safer than stopping suddenly. Doses are reduced gradually over weeks to months. Pauses help if symptoms or discontinuation effects appear. Choosing a stable period in life improves the chances. Tracking the Y-BOCS helps catch early signs of return. Support is available, and you don't have to handle it alone.
How can I tell discontinuation symptoms from OCD relapse?
Discontinuation symptoms appear within days of reducing or stopping and include dizziness, irritability and flu-like feelings. They usually ease over weeks. OCD relapse means obsessions and rituals return, often weeks to months later. Relapse tends to persist. Knowing the difference guides your response. Many people notice real improvement with the right plan.
Does ERP help prevent relapse after stopping medication?
The International OCD Foundation notes that ERP may reduce the risk of relapse after stopping an SSRI for some people. ERP skills remain useful after medication ends. Many clinicians suggest having solid ERP skills before a taper. Continued practice helps for most people. Therapy and medication can work together.
What should I do if my OCD returns?
Contact your clinician and consider returning to ERP practice. Restarting the same medication often helps, though response may take time. Relapse isn't a failure. It shows what your OCD needs over the long term. Some people choose long-term medication. Your clinician can help you decide on next steps.
Can I plan an OCD medication taper by video in New York?
Yes, SSRI taper planning and check-ins happen by secure video anywhere in New York. You need to be physically in New York during each visit. Dose changes go electronically to your pharmacy. The practice is in-network with Aetna and Cigna; confirm your New York plan with the office. You can contact the office between visits.
Where to go from here
- Right now, if you're not safe
- Call or text 988, or call 911.
- If you'd like an evaluation
- See how scheduling and telehealth work on the new patient page.
- If you want to keep reading
- Return to our New York OCD guide for more guides. For more help preparing and finding care, see NIMH’s tips for talking with your health care provider and FindTreatment.gov.
How We Reviewed This Page
Written by Steven Lockhart of Health Marketing Group and clinically reviewed by Gabriella I. Farkas, MD PhD, a board-certified psychiatrist. Clinical information comes from the sources listed below, and the page is reviewed every 180 days or when guidance changes.
What’s new: September 29, 2026. Page published.
References
- International OCD Foundation. Understanding Medication for OCD. https://iocdf.org/about-ocd/ocd-treatment-guide/understanding-medication/
- National Institute of Mental Health. Obsessive-Compulsive Disorder (OCD) statistics. https://www.nimh.nih.gov/health/statistics/obsessive-compulsive-disorder-ocd
- International OCD Foundation. What is OCD? https://iocdf.org/about-ocd/
- 988 Suicide & Crisis Lifeline. https://988lifeline.org/
- Tips for talking with your health care provider. https://www.nimh.nih.gov/health/publications/tips-for-talking-with-your-health-care-provider
- FindTreatment.gov. https://findtreatment.gov/